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Wnt3a mitigates acute lung injury by reducing P2X7
receptor-mediated alveolar epithelial type I cell death
Y Guo1, A Mishra1, T Weng1, NR Chintagari1, Y Wang1, C Zhao1, C Huang1 and L Liu*,1
Acute lung injury (ALI) is characterized by pulmonary endothelial and epithelial cell damage, and loss of the alveolar–capillary
barrier. We have previously shown that P2X7 receptor (P2X7R), a cell death receptor, is specifically expressed in alveolar
epithelial type I cells (AEC I). In this study, we hypothesized that P2X7R-mediated purinergic signaling and its interaction with
Wnt/b-catenin signaling contributes to AEC I death. We examined the effect of P2X7R agonist 20-30-O-(4-benzoylbenzoyl)-ATP
(BzATP) and Wnt agonist Wnt3a on AEC I death in vitro and in vivo. We also assessed the therapeutic potential of Wnt3a in a
clinically relevant ALI model of intratracheal lipopolysaccharide (LPS) exposure in ventilated mice. We found that the activation
of P2X7R by BzATP caused the death of AEC I by suppressing Wnt/b-catenin signaling through stimulating glycogen synthase
kinase-3b (GSK-3b) and proteasome. On the other hand, the activation of Wnt/b-catenin signaling by Wnt3a, GSK-3b inhibitor, or
proteasome inhibitor blocked the P2X7R-mediated cell death. More importantly, Wnt3a attenuated the AEC I damage caused by
intratracheal instillation of BzATP in rats or LPS in ventilated mice. Our results suggest that Wnt3a overrides the effect of P2X7R
on the Wnt/b-catenin signaling to prevent the AEC I death and restrict the severity of ALI.
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Acute lung injury (ALI) and its severe form, acute respiratory
distress syndrome (ARDS), are life-threatening diseases
caused by a variety of reasons, including sepsis, trauma,
and pneumonia.1 The alveolar epithelium consists of alveolar
epithelial type I cells (AEC I) and alveolar epithelial type II cells
(AEC II) and is believed to have an important role in the
pathogenesis of ALI. AEC I cover most of the alveolar surface
area and are the primary barrier of defense against the variety
of insults.2,3 They are more sensitive to injury in comparison
with other lung cells. Damage of AEC I is observed in all kinds of
ALI, leading to the deficiency of gas exchange and disruption of
fluid clearance. The molecular mechanisms of AEC I death
during ALI have been studied to some extent including the
regulation of several signaling pathways, such as TGF-b
pathway, NFkB pathway, and Fas/FasL-mediated pathway.4
Wnt is a family of secreted glycoprotein and has an
important role in development, tissue regeneration, and cell
fate determination.5 In the absence of Wnt ligands, the
intracellular b-catenin is phosphorylated by glycogen
synthase kinase-3b (GSK-3b) and degraded in proteasomes.
The binding of Wnt ligands with frizzled receptors leads to the
disruption of GSK-3b-mediated phosphorylation of b-catenin
and thus attenuation of proteasome-mediated degradation.
The stabilized b-catenin then translocates into the nucleus,
where it binds to T-cell factor (TCF)/lymphoid enhancer factor
(LEF) transcription factors to increase the transcription of its
downstream genes. We have previously shown that pleio-
trophin and miR-375 regulate Wnt/b-catenin signaling during
alveolar epithelial cell differentiation.6,7 Recent studies reveal
essential roles of Wnt/b-catenin signaling in the pathogenesis
of several lung diseases, including pulmonary fibrosis,8,9
asthma,10 and chronic obstructive pulmonary disease
(COPD).11,12 Activation of Wnt/b-catenin signaling promotes
AEC II survival,13 whereas deletion of b-catenin in AEC results
in an increased AEC death in bleomycin-induced lung injury
model.8 Transepithelial migration of neutrophils also activates
Wnt/b-catenin signaling in AEC II and accelerates the
epithelial repair.14 Thus, it is important to explore the potential
contribution of Wnt/b-catenin to AEC I damage during ALI.
P2X7 receptor (P2X7R) is a transmembrane ligand-gated
ion channel receptor activated by extracellular ATP.15 We
have previously found that P2X7R is specifically expressed in
AEC I and regulates lung surfactant secretion.16,17 However,
high concentrations of ATP or sustained stimulations could
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lead to apoptosis or necrosis in P2X7R-expressing cells.18,19
P2X7R knockout mice have shown a protective phenotype in
lipopolysaccharide (LPS)-induced ALI.20 Together with its
ability to modulate pulmonary inflammatory response,21
P2X7R could act as a potential regulator of AEC I cell death
in response to pathological insults.
In this study, we reported for the first time the important
integration of Wnt/b-catenin signaling and P2X7R-mediated
purinergic signaling in AEC I death during ALI. The finding
could be translated into a new therapeutic approach.
Results
P2X7R expression in lung cells. We have previously
shown that P2X7R is specifically expressed in AEC I of the
lung.16 Here we examined the expression of P2X7R in
several lung cell lines using western blot analysis. HEK293-
P2X7R cells, stably transfected cell line with P2X7R, were
used as a positive control. P2X7R expression was observed
in E10, an AEC I cell line and MLE15, a lung epithelial cell
line. However, HEK293 (a human epithelial kidney cell line),
R3/1 (a rat AEC I cell line), A549 (a human carcinoma AEC II
cell line), Pre-TII (a rat fetal AEC II cell line), H441 (a human
lung papillary adenocarcinoma epithelial cell line), RLE-6TN
(a rat lung AEC II cell line), and RFL-6 (a fetal lung fibroblast
cell line) had no P2X7R expression (Supplementary Figure
S1a in the online data supplement). The mRNA expression of
mouse P2X subunits was further analyzed using PCR.
P2X3R, P2X4R, P2X6R, and P2X7R subunits were highly
expressed in E10 cells. The expression levels of P2X1R and
P2X5R subunits were barely detectable, and P2X2R had no
expression in E10 cells. All of the P2X subunits were
expressed in the lung tissue (Supplementary Figure S1b).
Prolonged activation of P2X7R causes cell death. As
P2X7R is well known as a cell death receptor, we tested cell
viability upon the activation of P2X7R in E10 cells. Treatment
of E10 cells with 20-30-O-(4-benzoylbenzoyl)-ATP (BzATP), a
potent P2X7R agonist, for 12 h significantly decreased cell
viability in a dose-dependent manner as measured with
MTT assay and counting cell numbers (Figure 1a and
Supplementary Figure S2a). Direct cell lysis was monitored
by lactate dehydrogenase (LDH) release. High doses
(4200 mM) of BzATP dramatically increased LDH release
from dead cells (Figure 1b). To determine the specificity of
BzATP, oxidized ATP (oATP, a P2X7R antagonist) was
utilized to block P2X7R activity. Pre-incubation of E10 cells
with 500mM oATP totally attenuated the BzATP effect on cell
viability (Figure 1c) and LDH release (Supplementary Figure
S2b). We have previously shown that adenovirus-based
shRNAs significantly reduce P2XR protein levels in E10
cells.17The knockdown of P2X7R under the same conditions
also inhibited the BzATP-induced reduction in cell viability
(Figure 1d) and increase in LDH release (Supplementary
Figure S3a). In addition, BzATP did not induce cell death in
the lung cells, A549 and H441, that do not express P2X7R
(Supplementary Figure S3c and d). To determine whether
































































































































































Figure 1 Prolonged activation of P2X7R leads to E10 cell death. (a and b) E10 cells were incubated with different concentrations of BzATP for 12 h. Cell viability and LDH
release were measured. (c) E10 cells were treated with 400mM BzATP in the absence or presence of 500 mM oATP for 12 h, and cell viability was measured. (d) E10 cells
were transduced with adenovirus-based shRNA vectors (virus control (si-control), si-P2X7R1 and si-P2X7R2) for 4 days and then treated with 400mM BzATP for 12 h. Cell
viability was measured. (e) E10 cells were treated with 400mM BzATP for different times and recovered in a normal medium without BzATP for 8 h; cell viability was
determined. Data shown are means±S.E.M. of three independent experiments, and statistical significance was determined by one-way ANOVA analysis with post hoc
Tukey’s test. *Po0.001 versus control without any treatment or 0 time, **Po0.001 versus 400mM BzATP, and #Po0.005 versus si-control
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treated with BzATP for various times and were allowed to
recover in a normal medium without BzATP for 8 h. The cells
treated for up to 6 h were reversible. However, if the cells
were treated for longer than 8 h, the cells cannot be
recovered (Figure 1e).
Activation of P2X7R suppresses Wnt/b-catenin signaling.
Wnt/b-catenin signaling is important for cell proliferation
and survival.5 We determined whether P2X7R-mediated cell
death is due to downregulation of the Wnt/b-catenin
signaling. Several components of Wnt/b-catenin signaling
were analyzed after BzATP treatment. Western blot analysis
demonstrated that activated b-catenin and, to a lesser extent,
total b-catenin were downregulated by BzATP treatment
(Figure 2a). Proliferating cell nuclear antigen (PCNA) and
B-cell lymphoma 2 (Bcl-2), classic cell survival proteins were
reduced as well (Figure 2a). To further determine the effect
of BzATP on b-catenin/TCF/LEF activity, dual-luciferase
assay was used to determine the activities of TOPflash, a
TCF/LEF reporter plasmid expressing firefly luciferase.
BzATP significantly decreased TOPflash activity. However,
BzATP had no effect on the activity of FOPflash, a plasmid
containing a mutated TCF/LEF-binding site (Figure 2b).
Furthermore, we examined the mRNA expression of several
Wnt/b-catenin downstream genes: Bmp4, Axin2, Cyclin D1,
and Cyclin E1. Real-time PCR showed that the expression of
all these four target genes was inhibited (Figure 2c and
Supplementary Figure S4). Our results indicate that Wnt/b-
catenin signaling is suppressed by BzATP treatment.
Wnt3a blocks P2X7R-mediated cell death. To evaluate
the role of Wnt/b-catenin signaling in P2X7R-mediated cell
death, we activated Wnt/b-catenin signaling with its natural
ligand, Wnt3a, and examined its effect on P2X7R-mediated
depression of Wnt/b-catenin signaling and cell death.
Wnt3a_CM and Wnt5a_CM were obtained from L-cells that
stably expressed Wnt3a or Wnt5a. The medium from L-cells
(Con_CM) was used as a control. The pre-treatment of E10
cells with Wnt3a_CM prevented BzATP-mediated down-
regulation of total b-catenin and activated b-catenin
(Figure 2a), inhibition of TOPflash activity (Figure 2b) and
decrease in Axin2 (Figure 2c). As shown above, BzATP
treatment caused a decrease in cell number of E10 cells.
Wnt3a_CM, but not Wnt5a_CM or Con_CM, prevented the
BzATP-induced decrease in cell number (Figure 3a). Immu-
nostaining confirmed the activation of Wnt/b-catenin in E10
cells by Wnt3a as evidenced by nuclear translocation of
b-catenin (Figure 3a). Activation of Wnt/b-catenin signaling
by Wnt3a_CM in E10 cells also blocked P2X7-mediated
decrease in cell viability and increase in LDH release
(Figures 3b and c). Wnt3a_CM also protected primary
AEC-I-like cells from BzATP-induced cell death (Figure 3d).
YO-PRO dye uptake triggered by BzATP was not inhibited by
Wnt3a_CM (Supplementary Figure S5), indicating that
P2X7R activity itself is not affected by the activation of
Wnt/b-catenin signaling.
Activation of P2X7R stimulates GSK-3b and proteasome
activities. As Wnt3a is known to inhibit GSK-3b, resulting in
the activation of Wnt/b-catenin signaling,5 we examined
whether the downregulation of the Wnt/b-catenin pathway by
P2X7R is through the stimulation of GSK-3b. We monitored
the phosphorylation of Y216, an activated form of GSK-3b,
and the phosphorylation of S9, an inactivated form of
GSK-3b. The activation of P2X7R by BzATP increased the
phosphorylation of Y216 and decreased the phosphorylation
of S9 in GSK-3b without affecting the total GSK-3b
expression (Figure 4a). The result indicates that BzATP
stimulates GSK-3b activity. As expected, LiCl, a selective
inhibitor of GSK-3b, activated Wnt/b-catenin signaling as
indicated by the translocation of b-catenin into the nucleus
(Supplementary Figure S6) and reduced BzATP-mediated
cell death (Figures 4b and c).
As phosphorylated b-catenin by GSK-3b can be degraded
through the ubiquitin–proteasome system,5 we determined
whether BzATP affected proteasome activity. The treatment
of E10 cells with BzATP increased proteasome activity by
onefold (Figure 5a). Furthermore, MG-132, a proteasome
inhibitor, blocked BzATP-mediated reduction of cell viability
and increase in LDH release (Figures 5b and c).
Wnt3a reduces AEC I death in BzATP-induced ALI in
rats. To further investigate the role of P2X7R in AEC I death,











































































































Figure 2 Activation of P2X7R represses Wnt/b-catenin signaling. (a) E10 cells
were treated with 400mM BzATP for 0, 0.5, 2, 4, 8, and 12 h with or without 50%
Wnt3a_CM. Western blot analysis was carried out to determine the protein
expression of activated b-catenin, total b-catenin, Bcl-2, and PCNA. The expression
of b-actin was used as an internal control. (b) Two hundred nanograms TOPflash/
FOPflash and 1 ng pRL-TK, a control plasmid expressing a Renilla luciferase, were
transfected into E10 cells. Two days after transfection, E10 cells were treated with
400mM BzATP for 4 h with or without 50% Wnt3a_CM. Dual-luciferase assay was
performed and the results were expressed as the ratio of TOPflash/FOPflash
luciferase activity to pRL-TK. (c) E10 cells were stimulated with 400mM BzATP for
8 h with or without 50% Wnt3a_CM. The relative mRNA expression of Axin2 was
determined using real-time PCR and normalized to 18S rRNA. Data shown are
means±S.E.M. of three independent experiments. Statistical significance was
determined by ANOVA analysis with post hoc Tukey’s test. *Po0.001 versus
control. **Po0.001 versus BzATP without Wnt3a_CM
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Histological examination of lung tissues showed evidence of
diffused lung injury with significant alveolar septal necrosis
and edema formation seen in BzATP-treated mice
(Figure 6A). Bronchoalveolar lavage (BAL) cell analysis
indicated that activation of P2X7R led to a 3.2-fold increase
in alveolar macrophages. However, no significant neutrophil
infiltrations were observed (Figure 6B). BAL protein level was
elevated by BzATP (Supplementary Figure S7). LDH activity
in BAL, representing necrotic cell death, was also increased
by BzATP treatment (Figure 6C). An increase in T1a, an
AEC I marker, was observed in BAL of the BzATP-treated
group, indicating AEC I damage (Figure 6D). Instillation of
Wnt3a_CM together with BzATP dramatically reduced the
number of alveolar macrophages in BAL and BAL protein
concentration in comparison with Con_CM (Figure 6B and
Supplementary Figure S7). Wnt3a also significantly
decreased LDH and T1a release caused by BzATP
(Figures 6C and D). It was noted that both protein
concentration and LDH activity in BAL were higher in
Con_CM than in the PBS group. This is likely because of
the existence of proteins and LDH in the conditioned medium
(CM). These results indicated that Wnt3a can limit AEC I
death induced by activation of P2X7R in rats.
Wnt3a reduces AEC I death during LPS-induced ALI in a
ventilated mouse model. As bacterial infection and
mechanical ventilation (MV) are two major causes of
ALI/ARDS in clinical situations, we further took use of a
two-hit mouse model of ALI,22 which account for the
influences of both factors: LPS as bacterial infection and
noninjurious MV as clinical MV support. In comparison with
the Con_CM group, Wnt3a_CM dramatically reduced the
protein concentration in BAL fluid (Figure 7a). LDH activity in
BAL was also decreased 40% in the Wnt3a_CM-treated
group (Figure 7b). Most importantly, T1a in BAL was 70%
less in Wnt3a_CM-treated group than the control group
(Figure 7c). These results indicated that the activation of
canonical Wnt/b-catenin signaling can significantly reduce
AEC I death during ALI.
Discussion
In this study, we investigated the mechanisms of
P2X7R-mediated AEC I death during ALI. We found that the
activation of P2X7R caused AEC I death at least partly
by depressing the Wnt/b-catenin signaling pathway via







































































































































Figure 3 Wnt3a blocks P2X7R-mediated cell death. E10 cells were treated with 400mM BzATP for 8 h together with 50% Control (Con), Wnt3a, or Wnt5a CM.
(a) Immunostaining was carried out to determine b-catenin localization (Scale bar: 50 mm). (b and c) Cell viability and LDH release were measured. Data shown are
means±S.E.M. Statistical significance was determined by ANOVA analysis with post hoc Tukey’s test. *Po0.001 versus control. **Po0.001 versus Con_CM. n¼ 3.
(d) Primary AEC-I-like cells were treated with 0–400mM BzATP for 12 h with 50% Control (Con) or Wnt3a_CM, and Cell viability was measured
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signaling or inhibition of GSK-3b or proteasome prevented
P2X7R-mediated AEC I death. Furthermore, Wnt3a signifi-
cantly reduced the AEC I damage caused by intratracheal
instillation of BzATP in rats and LPS exposure in a ventilated
mouse model.
ATP-induced cell death has been observed in P2X7R-
expressing cells and can be blocked by P2X7R inhibitors.18,19
We have previously shown that P2X7R is highly expressed in
AEC I in the lung.16 This gives us an idea that P2X7R might
mediate AEC I death. This is supported by our current data
showing that the treatment of E10 with BzATP, a specific
P2X7R agonist, decreased cell viability in a dose-dependent
manner, which was blocked by oATP, a P2X7R antagonist.
Activating Wnt/b-catenin signaling inhibits apoptosis
induced by activating the intrinsic or mitochondrial pathway,
such as starvation or hydrogen peroxide,23 or the extracellular
or receptor pathway, such as TRAIL and TNF-a.23 Blocking
the Wnt/b-catenin pathway prevents cell proliferation and
results in apoptosis or necrosis.24 BzATP-induced AEC I
death is likely through downregulating the Wnt/b-catenin
signaling pathway since we observed BzATP activated
GSK-3b and proteasome activity and decreased b-catenin
protein level.
The high level of extracellular ATP released under
pathological conditions could be one of the major factors in
the pathogenesis of ALI.25 Extracellular ATP-induced cell
death has been observed in inflammatory diseases, including
colitis,26 spinal cord injury,27 and glomerulonephritis.28 It is
likely that in ALI, a high level of extracellular ATP acts on
P2X7R and induces cell death by apoptosis and/or necrosis.
P2X7R-deficient mice have a protective phenotype in LPS-
induced ALI20 and bleomycin-induced lung fibrosis25 in terms
of attenuated inflammation. P2X7R is also involved in the
pathogenesis of several chronic lung inflammatory diseases
such as asthma and emphysema, in which it functions as an
inflammatory mediator.29 In our study, direct activation of
P2X7R through intratracheal instillation of BzATP caused
severe AEC I death and LDH release into the alveolar space,
supporting the contribution of P2X7R to the pathogenesis
of ALI.
There are no standard methods for activating Wnt/b-catenin
signaling in the lung, an organ with more than 40 different
types of cells. Wnt3a is one of the reported ligands
constitutively present in the lung that can activate Wnt/b-
catenin signaling in alveolar epithelium.9 We demonstrated
that the activation of Wnt/b-catenin in the lungs by Wnt3a
reduced AEC I damage in two rodent models: BzATP-induced
ALI in rat and a clinically relevant LPS and MV model in mice.






















































Figure 4 Activation of P2X7R stimulates GSK-3b. (a) E10 cells were incubated
with 400 mM BzATP for different periods of time. The level of Tyr-216 (pY216) and
Ser-9 (pS9) phosphorylated GSK-3b and total GSK-3b were determined using
western blot analysis. (b and c) E10 cells were treated with 400mM BzATP together
with different concentrations of LiCl for 8 h. Cell viability and released LDH were
measured. Data shown are means±S.E.M. of three independent experiments.
Statistical significance was determined with ANOVA analysis with post hoc Tukey’s



































































































Figure 5 Proteasome is involved in P2X7R-mediated cell death. (a) E10 cells were treated with 400mM BzATP for 6 h. Cell lysate was incubated with Suc-LLVY-AMC.
Fluorescence was measured every 5 min for 30 min. The amount of AMC liberated per unit time was calculated as relative proteasome activity. (b and c) E10 cells were treated
with 400mM BzATP with or without 500mM MG-132 for 8 h. Cell viability and released LDH were measured. Values represent means±S.E.M. of three independent
experiments. Statistical significance was determined with ANOVA analysis with post hoc Tukey’s test. *Po0.001 versus Control. **Po0.001 versus BzATP alone
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activate Wnt/b-catenin signaling in mice. These inhibitors
attenuate the acute inflammation in blemocycin- and carra-
geenan-induced ALI.30 However, they also interfere with other
signaling including NFkB and NFAT. Our current findings
provide proof-of-concept to manipulate Wnt/b-catenin signal-
ing as an efficient way to limit AEC I death during ALI.
Taken together, we demonstrate that P2X7R induces
AEC I death by suppressing Wnt/b-catenin signaling via
activating GSK-3b and proteasome. Wnt3a overcomes
P2X7R-mediated downregulation of Wnt/b-catenin signaling
and prevents AEC I death during the acute phase of















































































































Figure 6 Wnt3a reduces AEC I death in BzATP-treated rat. The rats were intratracheally instilled with BzATP with control (Con) or Wnt3a CM for 24 h. (A) Histological
analysis. Paraffin sections (4mm) of the lungs were stained with H&E. Control (a), BzATP (b), BzATPþWnt3a_CM (c), and BzATPþCon_CM (d). Scale bar: 100mm.
(B) Total cell number and differential cell count in BAL. (C) LDH activity in BAL. (D) T1a protein in BAL. Representative bands of western blots were shown. Values represent
means±S.E.M. (n¼ 8 per group). Statistical significance was determined by one-way ANOVA analysis with post hoc Tukey’s test. *Po0.01 versus PBS alone group.


































































































Figure 7 Wnt3a reduces AEC I death in LPS and mechanical ventilation (LM)-induced ALI in mice. The mice were intratracheally instilled with LPS (0.5 mg/kg)
for 1 h and then ventilated for 2.5 h (12 ml/kg, a respiratory rate of 125 b.p.m. and 3 cm H2O PEEP). (a) Protein concentration in BAL. (b) LDH activity in BAL.
(c) T1a protein in BAL. Values represent means±S.E.M. (n¼ 8/group). Statistical significance was determined by Student’s t-test. *Po0.01 versus LMþCon_CM
group
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and P2X7R-mediated purinergic signaling provides insights
for future drug development and new therapeutic strategies of
exploration.
Materials and Methods
Cell culture. E10 cells, a gift from Dr. Mary Williams (Pulmonary Center,
Boston University School of Medicine, MA, USA), were cultured in CMRL 1066
supplemented with glutamax, penicillin/streptomycin, and 10% heat-inactivated
fetal bovine serum (FBS; Atlantic Biological, Miami, FL, USA). R3/1, a gift from
Dr. Roland Koslowski, Technische Universität Dresden, Germany, was maintained
in RPMI 1640 complemented with 10% FBS and penicillin/streptomycin. HEK 293
cells (ATCC, Manassas, VA, USA) and HEK293 cells stably expressing rat P2X7R
(HEK293-P2X7R), a gift from Dr. Annmarie Surprenant (University of Manchester,
Manchester, UK) were maintained in DMEM supplemented with 10% FBS and
100mM non-essential amino acids. A549 cells (ATCC) were cultured in RPMI
1640 medium containing 10% FBS. H441 cells (ATCC) were maintained in F-12K
medium complemented with 10% FBS. Cells were grown at 37 1C in a humidified
atmosphere containing 5% CO2.
Primary AEC-I-like cells. Primary AEC-I-like cells were obtained by culturing
primary AEC II on plastic plates for 7 days. To isolate AEC II, rat lung was perfused
using solution II (0.9% NaCl, 0.1% glucose, 30 mM HEPES, 6 mM KCl, 0.1 mg/ml
streptomycin sulfate, 0.07 mg/ml penicillin G, 0.07 mg/ml EGTA, 3 mM Na2HPO4,
and 3 mM NaH2PO4, pH 7.4) to clear the red blood cells. Then the lung was lavaged
with solution I (solution II plus 3 mM MgSO4 and 1.5 mM CaCl2) and digested with
elastase (3 units/ml) for 3 12 min at 37 1C. Then, the lung was chopped with a
Mcllwain tissue chopper, and the cell suspension was digested with 100 ng/ml
DNase I and filtered through 160- and 37-mm nylon mesh once and 15-mm nylon
mesh twice. Then cells were seeded on rat IgG-coated polystyrene bacteriological
plates twice for 45 and 30 min to remove macrophages. The unattached cells were
collected using centrifugation. The isolated AEC II had a purity of 90% and a viability
of over 98%. To obtain AEC-I-like cells, AEC II were seeded onto 96-well tissue
culture plastic dishes at a density of 1 106 cells/plate in MEM with 10% FBS. After
overnight culture, the culture media were changed to DMEM supplemented with
10% FBS. The medium was changed every 48 h until day 7.
Preparation of CM. Overexpressing soluble murine Wnt3a/Wnt5a cell lines
and control murine L-cell line (ATCC) were maintained in DMEM supplemented
with 10% FBS, 1% L-glutamine, and 0.4 mg/ml G418 (Invitrogen, Carlsbad, CA,
USA). To obtain Wnt3a-, Wnt5a-, or control (Con)-CM, cells were cultured in fresh
growth medium without G418 for 4 days and changed into fresh G418-free
medium for additional 3 days. The cultured media were mixed, sterile-filtered, and
stored at  80 1C until use. The activity of Wnt3a_CM was determined by a
TOPflash assay performed in 293T cells. Wnt3a_CM normally showed an
approximately sevenfold increase in the reporter activity compared with Con_CM.
To concentrate the soluble Wnt3a, 20 ml Wnt3a_CM was reduced into 2 ml 10
Wnt3a_CM using an ultrafiltration kit (Millipore, Billerica, MA, USA).
Knockdown of P2X7R in E10 cells. Two adenovirus-based shRNA
vectors, si-P2X7R1 and si-P2X7R,2 previously constructed in our laboratory
were utilized to knockdown P2X7R.17E10 cells were infected with virus control
(si-control), si-P2X7R,1 and si-P2X7R2 for 4 days at a multiplicity of infection of
100 before BzATP treatment.
Cell viability and LDH assays. At the end of BzATP (Sigma-Aldrich,
St. Louis, MO, USA) treatment, cell viability was assessed using the Cell Viability
Assay Kit (Millipore), which measured the activities of mitochondrial dehydro-
genases. Data were normalized to the control without any treatment. The release
of LDH was measured with a LDH assay kit (Diagnostic Chemicals Inc., Oxford,
CT, USA). The values were expressed as a percentage of actual LDH in the
medium to the maximal LDH released by freeze-thaw insults.
Western blot. The cells were lysed in M-PER Mammalian Protein Extraction
Reagent containing 1% Halt Protease Inhibitor Cocktail (Pierce, Rockford, IL,
USA) at 4 1C, followed by sonication and freeze-thaw cycles. The proteins were
separated in 10% SDS-PAGE and transferred to nitrocellulose membranes. The
membranes were stained with Ponceau-S to view the transfer quality. Then
the membranes were blocked for 1 h at room temperature with 5% dried milk in
Tris-buffered saline (10 mM Tris/HCl, 100 mM NaCl, and 0.05% Tween; pH 7.5;
TBS-T) and incubated overnight at 4 1C with anti-P2X7R (1 : 500, Sigma-Aldrich),
anti-activated b-catenin (1 : 1000, Millipore), anti-total b-catenin (1 : 2000, BD
Transduction Laboratories, San Jose, CA, USA), anti-Bcl-2 (1 : 1000, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), anti-PCNA (1 : 2000, Santa Cruz
Biotechnology), anti-GSK-3b (1 : 2000, BD Transduction Laboratories), anti-
GSK-3b (pY216) (1 : 1000, BD Transduction Laboratories), anti-GSK-3b (pS9)
(1 : 1000, Cell Signaling Technology, Danvers, MA, USA), anti-b-actin (1 : 2000,
Sigma), and anti-GAPDH (1 : 400, Santa Cruz Biotechnology) antibodies. The
blots were then rinsed in TBS-T and incubated for 1 h at room temperature with
goat anti-rabbit, or goat anti-mouse secondary antibodies, coupled to horseradish
peroxidase (1 : 2000, Jackson Immunoresearch, West Grove, PA, USA). After
being washed, the blots were developed using SuperSignal West Pico
Chemiluminescent Substrate (Pierce).
Quantitative real-time PCR. Total RNA was extracted from cells or tissues
using TRI-Reagent (Molecular Research Center, Cincinnati, OH, USA) following the
manufacturer’s instructions. RNA was digested with TURBO DNase (Ambion,
Austin, TX, USA) to remove the genomic DNA contamination. One microgram of
RNA was reverse-transcribed into cDNA using M-MLV reverse transcriptase
(Invitrogen), random primers, and oligo dT (Promega, Madison, WI, USA). Real-
time PCR was carried out on 7900HT Fast Real-Time PCR System using SYBR
Green I detection Master Mix (Eurogentec, San Diego, CA, USA). The primers
were designed using the Primer Express software (Applied Biosystems, Foster City,
CA, USA) and listed in Supplementary Table 1. PCR involved an initial denaturation
step at 94 1C for 5 min, followed by 40 cycles of amplification (94 1C for 30 s, 60 1C
for 1 min). A dissociation curve was generated after each PCR to view the
specificity of the amplification. All of the data were normalized to 18S rRNA.
Immunofluorescence. E10 cells were cultured on 24-well plastic plates.
Before collection, the cells were briefly washed with PBS and fixed with 4%
paraformaldehyde for 15 min. After being washed with PBS, the cells were
permeabilized with 0.3% Triton X-100 for 10 min and blocked with 10% FBS for 1 h
at room temperature. After rinsing, the cells were incubated overnight with primary
antibodies against b-catenin (1 : 200). Subsequently, cells were washed with PBS
and incubated with Alexa 568-conjugated goat anti-mouse IgG (Invitrogen) for 1 h.
Images were acquired using a Nikon Eclipse TE-2000 inverted fluorescence
microscope (Nikon Instruments, Melville, NY, USA).
TOPflash assay. E10 cells were seeded in 96-well plastic plates. After
reaching 85% confluence, the cells were transfected with 1 ng Renilla luciferase
control plasmid phRL-TK (Promega) and 20 ng LEF/TCF reporter plasmid
TOPflash (Millipore) or FOPflash (a negative control plasmid for TOPflash, which
has mutated LEF/TCF-binding sites) using Lipofectamine 2000 (Invitrogen). After
24 h, cells were treated with 400mM BzATP for 0–12 h. Dual-luciferase assay was
performed using the Dual-Luciferase Reporter Assay System (Promega).
Figure 8 A model of P2X7R-induced AEC I death and Wnt3a-mediated
protection. Activation of P2X7R by ATP activates GSK-3b and proteasome and
leads to the degradation of b-catenin. This causes AEC I cell death. With the
addition of Wnt3a, the activity of GSK-3b is inhibited. b-catenin is accumulated in
the cytoplasmic and translocated into the cell nucleus, which enhances AEC I cell
survival
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Proteasome activity assay. To measure proteasome activity, 100mg of
cell lysate was diluted with assay buffer (50 mM Tris (pH 7.4), 5 mM MgCl2, 2 mM
dithiothreitol, and 2 mM ATP) to a final volume of 1 ml and incubated with 50 mM
fluorogenic proteasome substrate Suc-LLVY-AMC (AnaSpec, Fremont, CA, USA).
Proteolytic activities, reflected by the release of the fluorescent group, 7-amido-4-
methylcoumarin (AMC), were continuously monitored in 30 min at 37 1C by a
fluorescence plate reader (Spectramax M2, Molecular Devices, Sunnyvale, CA,
USA) with excitation and emission wavelengths of 380 and 460 nm, respectively.
Animals. Male C57BL/6N mice (6–8 weeks old) were purchased from Jackson
Laboratory (Bar Harbor, ME, USA). Male Sprague–Dawley rats were purchased
from Charles River Breeding Laboratories (Wilmington, MA, USA). All the animals
were housed and cared for by the Laboratory Animal Resource Unit, Oklahoma
State University. Experimental protocols were reviewed and approved by the
Institutional Animal Care and Use Committee of Oklahoma State University.
BzATP-induced ALI in rat. Male Sprague–Dawley rats (275–300 g) were
divided into four groups (n¼ 8/group): (1) vehicle (200ml PBS), (2) BzATP (10 mg/kg
b.w. BzATP in 200ml PBS), (3) BzATP and Wnt3a_CM (10 mg/kg b.w. BzATP in
100ml PBS, and 100ml 10X Wnt3a_CM), and (4) BzATP and Con_CM (10 mg/kg
b.w. BzATP in 100ml PBS, and 100ml 10X Con_CM). Rats were anesthetized with
intraperitoneal injection of ketamine (40 mg/kg b.w.) and xylazine (8 mg/kg b.w.). All of
the reagents were intratracheally instilled. Twenty-four hours after intratracheal
instillation, a tracheotomy was performed. Bronchoalveolar lavage (BAL) was
collected by lavaging the right lungs with 10 ml of normal saline. After centrifugation at
380 g for 10 min at 4 1C, the cell pellets were resuspended in 1 ml of normal saline.
Cell-free BAL and tissue samples of lavaged right lungs were immediately frozen in
liquid nitrogen and stored at  80 1C for subsequent analysis. Unlavaged left lungs
were fixed in 4% paraformaldehyde for histological analysis.
LPS-induced ALI in a ventilated mouse model. Male C57BL/6N mice
(8 weeks) were divided into four groups (n¼ 8/group): (1) LPSs from Escherichia
coli 055:B5 (0.5 mg/kg b.w.) in 20ml 10X Wnt3a CM, (2) LPS 0.5 mg/kg b.w. in
20ml 10X Con_CM, (3) LPS 0.5 mg/kg b.w. in 20 ml normal saline, and (4) Control,
without LPS and MV. LPS was intratracheally delivered into the lung. One hour
after intratracheal instillation, mice were ventilated with a tidal volume of 12 ml/kg,
a rate of 125 b.p.m., and 3 cm H2O PEEP for 2.5 h. At the end of ventilation, a
tracheotomy was performed. The lungs were lavaged with 1 ml of normal saline
three times. BAL was collected and centrifuged at 380 g for 10 min at 4 1C. BAL
cell pellets were resuspended in 200ml of normal saline for subsequent analysis.
Cell-free BAL fluid and lavaged lung tissue samples were frozen in liquid nitrogen
and stored in  80 1C freezer.
BAL analysis. Protein concentrations in the BAL fluid were determined using
a Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA). The total
number of cells in BAL was counted with a hemocytometer. Differential cell count
was performed on the BAL cells visualized with Wright–Giemsa staining. LDH
activity in the BAL fluid was determined using a Cytotoxicity Detection kit (Roche
Applied Sciences, Indianapolis, IN, USA) using type III L-lactic dehydrogenase
(Sigma-Aldrich) as standards.
Western blot for T1a in BAL. For rat samples, BAL fluid (70 ml) was added
with 7ml SDS sample buffer (62.5 mM Tris HCl, pH 6.8, containing 5%
2-mercaptoethanol, 2% SDS, 10% glycerol, and 0.01% bromophenol blue) and
heated at 95 1C until 25ml volume was reached. A monoclonal anti-T1a (1 : 2000,
a gift from Dr. Mary C Williams, Boston University) antibody was used as a primary
antibody. For mouse samples, BAL fluid (20ml) was added with 4 ml SDS sample
buffer and heated at 95 1C for 10 min. A hamster anti-T1a (1 : 2000, 8.1.1, DHSB,
Iowa City, IO, USA) was used as a primary antibody. Films were developed and
scanned. The densities of bands were quantified using the ImageJ software
(National Institutes of Health, Bethesda, MD, USA (http://rsb.info.nih.gov/ij/)).
Statistical analysis. The results were analyzed using one-way ANOVA with
post hoc Tukey’s test for multiple comparisons of control and treatment groups, or
Student’s t-test using GraphPad Prism (version 6). All results were reported as
means±S.E.M. (n¼ 3–8 for each condition).
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. We thank Dr. Mary Williams (Boston University) for
providing anti-T1a antibody and E10 cells with the permission of Dr. Al Malkinson
(University of Colorado), Dr. Annmarie Surprenant (University of Manchester) for
HEK293-P2X7R cells, Dr. Roland Koslowski (Dresden University of Technology) for
R3/1 cells, Dr. Joseph Alcorn (University of Texas Health Sciences Center at
Houston) for MLE15 cells, Dr. Rama Mallamaplli (University of Pittsburgh) for Pre-
TII cells. Hamster anti-mouse T1a antibody developed by Dr. Andrew Farr
(University of Washington) was obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the NICHD and maintained by
The University of Iowa, Department of Biology, Iowa City, IA 52242, USA. This work
was supported by the National Heart, Lung and Blood Institute under Award
Numbers R01HL083188, 071628, and 052146 (to LL) and the National Institute of
General Medical Sciences under award number P20GM103648 (Molecular Biology
Core facility). The content is solely the responsibility of the authors and does not
necessarily represent the official views of the National Institutes of Health. YG was
supported by predoctoral fellowships (no. 09PRE2300211) from the American Heart
Association.
1. Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and
treatment. Annu Rev Pathol 2011; 6: 147–163.
2. Dobbs LG, Johnson MD, Vanderbilt J, Allen L, Gonzalez R. The great big alveolar TI cell:
evolving concepts and paradigms. Cell Physiol Biochem 2010; 25: 55–62.
3. Chen J, Chen Z, Chintagari NR, Bhaskaran M, Jin N, Narasaraju T et al. Alveolar type I
cells protect rat lung epithelium from oxidative injury. J Physiol 2006; 572: 625–638.
4. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can
cells die? Am J Physiol Lung Cell Mol Physiol 2008; 294: L632–L641.
5. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012; 149: 1192–1205.
6. Weng T, Gao L, Bhaskaran M, Guo Y, Gou D, Narayanaperumal J et al. Pleiotrophin
regulates lung epithelial cell proliferation and differentiation during fetal lung development
via beta-catenin and Dlk1. J Biol Chem 2009; 284: 28021–28032.
7. Wang Y, Huang C, Reddy CN, Bhaskaran M, Weng T, Guo Y et al. miR-375 regulates rat
alveolar epithelial cell trans-differentiation by inhibiting Wnt/beta-catenin pathway. Nucleic
Acids Res 2013; 41: 3833–3844.
8. Tanjore H, Degryse AL, Crossno PF, Xu XC, McConaha ME, Jones BR et al. beta-catenin
in the alveolar epithelium protects from lung fibrosis after intratracheal bleomycin.
Am J Respir Crit Care Med 2013; 187: 630–639.
9. Konigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A et al. WNT1-inducible
signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with
idiopathic pulmonary fibrosis. J Clin Invest 2009; 119: 772–787.
10. Sharma S, Tantisira K, Carey V, Murphy AJ, Lasky-Su J, Celedon JC et al. A role for
WNT-signaling genes in the pathogenesis of impaired lung function in asthma. Am J Respir
Crit Care Med 2009; 181: 328–336.
11. Kneidinger N, Yildirim AO, Callegari J, Takenaka S, Stein MM, Dumitrascu R et al.
Activation of the WNT/beta-catenin pathway attenuates experimental emphysema.
Am J Respir Crit Care Med 2011; 183: 723–733.
12. Wang R, Ahmed J, Wang G, Hassan I, Strulovici-Barel Y, Hackett NR et al.
Down-regulation of the canonical Wnt beta-catenin pathway in the airway epithelium of
healthy smokers and smokers with COPD. PLoS One 2011; 6: e14793.
13. Flozak AS, Lam AP, Russell S, Jain M, Peled ON, Sheppard KA et al. {beta}-catenin/TCF
signaling is activated during lung injury and promotes the survival and migration of alveolar
epithelial cells. J Biol Chem 2009; 285: 3157–3167.
14. Zemans RL, Briones N, Campbell M, McClendon J, Young SK, Suzuki T et al. Neutrophil
transmigration triggers repair of the lung epithelium via beta-catenin signaling. Proc Natl
Acad Sci USA 2011; 108: 15990–15995.
15. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease.
Nature 2006; 442: 527–532.
16. Chen Z, Jin N, Narasaraju T, Chen J, McFarland LR, Scott M et al. Identification of two
novel markers for alveolar epithelial type I and II cells. Biochem Biophys Res Commun
2004; 319: 774–780.
17. Mishra A, Chintagari NR, Guo Y, Weng T, Su L, Liu L. Purinergic P2X7 receptor
regulates lung surfactant secretion in a paracrine manner. J Cell Sci 2011; 124(Pt 4):
657–668.
18. Hanley PJ, Kronlage M, Kirschning C, del RA, Di VF, Leipziger J et al.
Transient P2X7 receptor activation triggers macrophage death independent of Toll-like
receptors 2 and 4, caspase-1, and pannexin-1 proteins. J Biol Chem 2012; 287:
10650–10663.
19. Jun DJ, Kim J, Jung SY, Song R, Noh JH, Park YS et al. Extracellular ATP mediates
necrotic cell swelling in SN4741 dopaminergic neurons through P2X7 receptors. J Biol
Chem 2007; 282: 37350–37358.
20. Moncao-Ribeiro LC, Cagido VR, Lima-Murad G, Santana PT, Riva DR, Borojevic R et al.
Lipopolysaccharide-induced lung injury: role of P2X7 receptor. Respir Physiol Neurobiol
2011; 179: 314–325.
21. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M et al. The P2X7 receptor: a
key player in IL-1 processing and release. J Immunol 2006; 176: 3877–3883.
Wnt3a and lung type I cell death
Y Guo et al
8
Cell Death and Disease
22. Altemeier WA, Matute-Bello G, Frevert CW, Kawata Y, Kajikawa O, Martin TR et al.
Mechanical ventilation with moderate tidal volumes synergistically increases lung cytokine
response to systemic endotoxin. Am J Physiol Lung Cell Mol Physiol 2004; 287: L533–L542.
23. Doubravska L, Simova S, Cermak L, Valenta T, Korinek V, Andera L. Wnt-expressing rat
embryonic fibroblasts suppress Apo2L/TRAIL-induced apoptosis of human leukemia cells.
Apoptosis 2008; 13: 573–587.
24. You L, He B, Xu Z, Uematsu K, Mazieres J, Fujii N et al. An anti-Wnt-2 monoclonal antibody
induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res
2004; 64: 5385–5389.
25. Riteau N, Gasse P, Fauconnier L, Gombault A, Couegnat M, Fick L et al. Extracellular ATP
is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir
Crit Care Med 2010; 182: 774–783.
26. Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA et al.
Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during
colitis. Nat Med 2012; 18: 600–604.
27. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P et al. P2X7 receptor inhibition
improves recovery after spinal cord injury. Nat Med 2004; 10: 821–827.
28. Taylor SR, Turner CM, Elliott JI, McDaid J, Hewitt R, Smith J et al. P2X7 deficiency
attenuates renal injury in experimental glomerulonephritis. J Am Soc Nephrol 2009; 20:
1275–1281.
29. Lucattelli M, Cicko S, Muller T, Lommatzsch M, de CG, Cardini S et al. P2X7
receptor signalling in the pathogenesis of smoke-induced lung inflammation and
emphysema. Am J Respir Cell Mol Biol 2011; 44: 423–429.
30. Cuzzocrea S, Crisafulli C, Mazzon E, Esposito E, Muia C, Abdelrahman M et al. Inhibition
of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced
lung injury in mice. Br J Pharmacol 2006; 149: 687–702.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution-NonCommercial-
ShareAlike 3.0 Unported License. The images or other third party
material in this article are included in the article’s Creative Commons
license, unless indicated otherwise in the credit line; if the material is
not included under the Creative Commons license, users will need to
obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/
licenses/by-nc-sa/3.0/
Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)
Wnt3a and lung type I cell death
Y Guo et al
9
Cell Death and Disease
